SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-037550
Filing Date
2018-06-13
Accepted
2018-06-13 18:30:02
Documents
1
Period of Report
2018-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4104
  Complete submission text file 0001209191-18-037550.txt   5818
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SELLAS LIFE SCIENCES GROUP, INC. 2000 CROW CANYON PLACE, STE. 380 SAN RAMON CA 94583
Business Address
Lopez Fabio (Reporting) CIK: 0001724449 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 18897669